ASPG and neoplasm: The recombinant L-asparaginase was found to be efficient against K-562 and HepG-2 tumor cells at low concentrations; at 2.58 IU/ml, 61% of HepG-2 cells and 59% of K-562 cells were destroyed by the enzyme.